Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands
Objective: There is limited evidence on patients' adherence and the impact of the prescribed dosing regimen in non-vitamin-K oral anticoagulants (NOACs). We aimed to assess secondary adherence to NOACs and to determine the impact of the dosing regimen in patients with atrial fibrillation. Methods: Patients using a NOAC between 2009 and 2013 were identified from the nation-wide Swedish Prescribed Drug Register and the Dutch regional IADB.nl database. Patients using a consistent dosage for at least 180 consecutive days were included. Adherence was calculated using the medication possession ratio... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2018 |
Reihe/Periodikum: | Jacobs , M S , Schouten , J F , de Boer , P T , Hoffmann , M , Levin , L-Å & Postma , M J 2018 , ' Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 10 , pp. 1839-1847 . https://doi.org/10.1080/03007995.2018.1459528 |
Schlagwörter: | Adherence / non-vitamin-K oral anticoagulants / anticoagulation / dosing regimen / apixaban / dabigatran / rivaroxaban / DAILY DOSING FREQUENCY / MEDICATION ADHERENCE / DABIGATRAN ADHERENCE / RISK FACTOR / WARFARIN / STROKE / IMPACT / PERSISTENCE / COHORT |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26824878 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/2d9781ce-1b22-40c5-8b7b-6e3bcaa63d38 |